Top Markets
Coin of the day
Eli Lilly Eli Lilly

Eli Lilly

LLY
Clasificación en acciones #14
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Precio por acción
$1,179.09
Capitalización bursátil
$1.110T
Cambio (1 día)
0.76%
Cambio (1 año)
54.84%
País
US
Comercio Eli Lilly (LLY)

Categoría

Precio LLY con Capital del mercado a B
Eli Lilly Eli Lilly
LLY
$1,179.09
Capitalización de mercado de Eli Lilly(LLY)
Capitalización bursátil: $1.110T
A fecha de July 2026, Eli Lilly tiene una capitalización de mercado de $1.110T. Esto convierte a Eli Lilly en la 14th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Eli Lilly desde 1972 hasta 2026
LLY en comparación con los más populares 5 títulos stocks
Precio por LLY Activo B Capital del mercado en B Resultados
Eli Lilly Eli Lilly
$5,216.15 $1.110T
$4.912T +342.39%
Eli Lilly Eli Lilly
$5,205.00 $1.110T
$4.902T +341.44%
Eli Lilly Eli Lilly
$4,452.76 $1.110T
$4.193T +277.64%
Eli Lilly Eli Lilly
$3,106.44 $1.110T
$2.925T +163.46%
Eli Lilly Eli Lilly
$2,824.00 $1.110T
$2.659T +139.51%